Raymond James & Associates’s Nuveen Core Plus Impact Fund NPCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$198K Buy
16,692
+4,881
+41% +$55.8K ﹤0.01% 3647
2024
Q2
$129K Buy
+11,811
New +$124K ﹤0.01% 3695
2023
Q4
Sell
-12,705
Closed -$116K 3907
2023
Q3
$116K Sell
12,705
-1,203
-9% -$11.8K ﹤0.01% 3571
2023
Q2
$139K Buy
13,908
+2,453
+21% +$24.8K ﹤0.01% 3564
2023
Q1
$117K Sell
11,455
-673
-6% -$7.32K ﹤0.01% 3615
2022
Q4
$126K Buy
+12,128
New +$127K ﹤0.01% 3591

Other funds holding NPCT

Raymond James & Associates's NPCT Position: Q3 2024 in Review

Raymond James & Associates increased its Nuveen Core Plus Impact Fund (NPCT) stake by 41% in Q3 2024, buying an estimated $55.8K and bringing the position to 16,692 shares worth $198K. The position accounts for ﹤0.01% of the portfolio, ranked #3647.

Raymond James & Associates first reported a position in NPCT in Q4 2022 and has held it in 6 quarters since. 38 funds tracked by Wall St. Rank hold NPCT as of Q3 2024.

  • Raymond James & Associates held 16,692 shares of Nuveen Core Plus Impact Fund worth $198K as of Q3 2024.
  • Raymond James & Associates bought 4,881 Nuveen Core Plus Impact Fund shares in Q3 2024, an estimated $55.8K.
  • Nuveen Core Plus Impact Fund made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3647 holding.
  • Raymond James & Associates first reported a position in Nuveen Core Plus Impact Fund in Q4 2022 and has held it in 6 quarters since.
  • 38 funds tracked by Wall St. Rank held Nuveen Core Plus Impact Fund as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.